<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d406" origId="Epirubicin"><sentence id="DrugDDI.d406.s0" origId="s0" text="ELLENCE when used in combination with other cytotoxic drugs may show on-treatment additive toxicity, especially hematologic and gastrointestinal effects."><entity id="DrugDDI.d406.s0.e0" origId="s0.p0" charOffset="0-7" type="drug" text="ELLENCE"/><entity id="DrugDDI.d406.s0.e1" origId="s0.p4" charOffset="38-59" type="drug" text="other cytotoxic drugs"/><pair id="DrugDDI.d406.s0.p0" e1="DrugDDI.d406.s0.e0" e2="DrugDDI.d406.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d406.s1" origId="s1" text="Concomitant use of ELLENCE with other cardioactive compounds that could cause heart failure (e.g., calcium channel blockers), requires close monitoring of cardiac function throughout treatment."><entity id="DrugDDI.d406.s1.e0" origId="s1.p12" charOffset="19-26" type="drug" text="ELLENCE"/><entity id="DrugDDI.d406.s1.e1" origId="s1.p20" charOffset="99-123" type="drug" text="calcium channel blockers"/><pair id="DrugDDI.d406.s1.p0" e1="DrugDDI.d406.s1.e0" e2="DrugDDI.d406.s1.e1" interaction="true"/></sentence><sentence id="DrugDDI.d406.s2" origId="s2" text="There are few data regarding the coadministration of radiation therapy and epirubicin."><entity id="DrugDDI.d406.s2.e0" origId="s2.p34" charOffset="75-85" type="drug" text="epirubicin"/></sentence><sentence id="DrugDDI.d406.s3" origId="s3" text="In adjuvant trials of epirubicin-containing CEF-120 or FEC-100 chemotherapies, breast irradiation was delayed until after chemotherapy was completed."><entity id="DrugDDI.d406.s3.e0" origId="s3.p36" charOffset="22-32" type="drug" text="epirubicin"/></sentence><sentence id="DrugDDI.d406.s4" origId="s4" text="This practice resulted in no apparent increase in local breast cancer recurrence relative to published accounts in the literature."/><sentence id="DrugDDI.d406.s5" origId="s5" text="A small number of patients received epirubicin-based chemotherapy concomitantly with radiation therapy but had chemotherapy interrupted in order to avoid potential overlapping toxicities."><entity id="DrugDDI.d406.s5.e0" origId="s5.p56" charOffset="36-46" type="drug" text="epirubicin"/></sentence><sentence id="DrugDDI.d406.s6" origId="s6" text="It is likely that use of epirubicin with radiotherapy may sensitize tissues to the cytotoxic actions of irradiation."><entity id="DrugDDI.d406.s6.e0" origId="s6.p69" charOffset="25-35" type="drug" text="epirubicin"/></sentence><sentence id="DrugDDI.d406.s7" origId="s7" text="Administration of ELLENCE after previous radiation therapy may induce an inflammatory recall reaction at the site of the irradiation."><entity id="DrugDDI.d406.s7.e0" origId="s7.p77" charOffset="18-25" type="drug" text="ELLENCE"/></sentence><sentence id="DrugDDI.d406.s8" origId="s8" text="Epirubicin is extensively metabolized by the liver."><entity id="DrugDDI.d406.s8.e0" origId="s8.p84" charOffset="0-10" type="drug" text="Epirubicin"/><entity id="DrugDDI.d406.s8.e1" origId="s8.p88" charOffset="45-50" type="drug" text="liver"/><pair id="DrugDDI.d406.s8.p0" e1="DrugDDI.d406.s8.e0" e2="DrugDDI.d406.s8.e1" interaction="false"/></sentence><sentence id="DrugDDI.d406.s9" origId="s9" text="Changes in hepatic function induced by concomitant therapies may affect epirubicin metabolism, pharmacokinetics, therapeutic efficacy, and/or toxicity."><entity id="DrugDDI.d406.s9.e0" origId="s9.p95" charOffset="72-82" type="drug" text="epirubicin"/></sentence><sentence id="DrugDDI.d406.s10" origId="s10" text="Cimetidine increased the AUC of epirubicin by 50%."><entity id="DrugDDI.d406.s10.e0" origId="s10.p100" charOffset="0-10" type="drug" text="Cimetidine"/><entity id="DrugDDI.d406.s10.e1" origId="s10.p103" charOffset="32-42" type="drug" text="epirubicin"/><pair id="DrugDDI.d406.s10.p0" e1="DrugDDI.d406.s10.e0" e2="DrugDDI.d406.s10.e1" interaction="true"/></sentence><sentence id="DrugDDI.d406.s11" origId="s11" text="Cimetidine treatment should be stopped during treatment with ELLENCE."><entity id="DrugDDI.d406.s11.e0" origId="s11.p105" charOffset="0-10" type="drug" text="Cimetidine"/><entity id="DrugDDI.d406.s11.e1" origId="s11.p110" charOffset="61-68" type="drug" text="ELLENCE"/><pair id="DrugDDI.d406.s11.p0" e1="DrugDDI.d406.s11.e0" e2="DrugDDI.d406.s11.e1" interaction="true"/></sentence><sentence id="DrugDDI.d406.s12" origId="s12" text="Drug-Laboratory Test Interactions There are no known interactions between ELLENCE and laboratory tests."><entity id="DrugDDI.d406.s12.e0" origId="s12.p114" charOffset="74-81" type="drug" text="ELLENCE"/></sentence></document>